Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
148
-
Total 13F shares, excl. options
-
47.1M
-
Shares change
-
-3.11M
-
Total reported value, excl. options
-
$774M
-
Value change
-
-$64.9M
-
Put/Call ratio
-
0.82
-
Number of buys
-
74
-
Number of sells
-
-58
-
Price
-
$16.41
Significant Holders of OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) as of Q1 2021
179 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - COMMON STOCK as of Q1 2021.
OCULAR THERAPEUTIX, INC - COMMON STOCK (OCUL) has 148 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47.1M shares
of 159M outstanding shares and own 29.57% of the company stock.
Largest 10 shareholders include Opaleye Management Inc. (6.48M shares), BlackRock Inc. (5.87M shares), SUMMER ROAD LLC (5.62M shares), VANGUARD GROUP INC (3.64M shares), DELTEC ASSET MANAGEMENT LLC (2.1M shares), VICTORY CAPITAL MANAGEMENT INC (1.55M shares), STATE STREET CORP (1.52M shares), EMERALD MUTUAL FUND ADVISERS TRUST (1.35M shares), EMERALD ADVISERS, LLC (1.29M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.23M shares).
This table shows the top 148 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.